India  

Covaxin effective on UK virus strain of Covid-19: ICMR

IndiaTimes Wednesday, 27 January 2021
An Indian Council of Medical Research (ICMR) study on Covaxin shows a comparable neutralization activity of the vaccinated individuals against UK-variant strain.
0
shares
ShareTweetSavePostSend
 
Video Credit: ANI - Published
News video:

"Covaxin is successful in tackling UK strain," informs ICMR 01:55

Indian Council of Medical Research DG, Balram Bhargava announced that the Covaxin is successful in tackling UK strain. He further informed that UK variant strain is now present in 70 countries and 164 cases have been identified in India. "UK variant strain is now present in 70 countries and we've...

You Might Like


💡 newsR Knowledge: Other News Mentions

Indian Council of Medical Research Indian Council of Medical Research Government Organization

COVID-19: India reports spike of over 2.6 lakh cases [Video]

COVID-19: India reports spike of over 2.6 lakh cases

COVID-19 situation continues to deteriorate across the country. Daily cases breached 2-lakh mark for 4th consecutive day on April 18 as India reported 2,61,500 new cases. Country's COVID caseload is at 1,47,88,109 with 18,01,316 active cases. 1,38,423 people were discharged in last 24 hours taking total recoveries to 1,28,09,643. With 1,501 new deaths, death toll has mounted to 1,77,150. According to Indian Council of Medical Research (ICMR), 26,65,38,416 samples tested for COVID-19. The COVID vaccination drive is underway across country. So far 12,26,22,590 COVID vaccine jabs have been inoculated.

Credit: ANI    Duration: 01:43Published
COVID-19: India continues to report spike of over 2 lakh cases [Video]

COVID-19: India continues to report spike of over 2 lakh cases

COVID-19 situation continues to deteriorate across the country. Daily cases breached 2-lakh mark on third consecutive day on April 17 as India reported 2,34,692 new cases. Country's COVID caseload is at 1,45,26,609 with 16,79,740 active cases. 1,23,354 people were discharged in last 24 hours taking total recoveries to 1,26,71,220. With 1,341 new deaths, death toll has mounted to 1,75,649. According to Indian Council of Medical Research (ICMR), 26,49,72,022 samples tested for COVID-19. The COVID vaccination drive is underway across country. So far 11,99,37,641 COVID vaccine jabs have been inoculated.

Credit: ANI    Duration: 01:43Published
COVID-19: India records highest ever spike of 2.17 lakh cases [Video]

COVID-19: India records highest ever spike of 2.17 lakh cases

COVID-19 situation continues to deteriorate across the country as there is no holding back to surge in cases. A day after daily cases breached 2-lakh mark, in April 15 India reported 2,17,353 new cases. Country's COVID caseload is at 1,42,91,917 with 15,69,743 active cases. 1,18,302 people were discharged in last 24 hours taking total recoveries to 1,25,47,866. With 1,185 new deaths, death toll has mounted to 1,74,308. According to Indian Council of Medical Research (ICMR), 26,34,76,625 samples tested for COVID-19. The COVID vaccination drive is underway across country. So far 11,72,23,509 COVID vaccine jabs have been inoculated.

Credit: ANI    Duration: 01:40Published

BBV152 BBV152 Vaccine against COVID-19

Use entire national capacity to step up Covid vaccine production, PM tells officials

The PM’s directive came at a review meeting on the Covid situation on Saturday a day after he had overseen an assessment of oxygen supplies and production and..
IndiaTimes

Covaxin production to be increased to 100 million doses per month by September 2021: Centre

Union health minister Harsh Vardhan said financial support is being provided to four manufacturers to expand Covaxin vaccine production.
DNA

India to increase Covaxin production to 100 million doses per month by September

The Union government on Friday said it will amp up the production of the indigenously developed Covaxin vaccine to 100 million doses per month by September. As..
IndiaTimes
Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin [Video]

Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin

The Central Government has given permission to Haffkine Institute to produce Bharat Biotech's Covaxin. CM Uddhav Thackeray thanked PM Modi through a tweet by CM office, Maharashtra on April 15, "The Dept of Science and Technology, Government of India, has granted approval to Haffkine Institute to produce Bharat Biotech's Covaxin vaccine on a transfer of technology basis. CM Uddhav Balasaheb Thackeray has thanked the Hon'ble PM Shri@narendramodi for approving this request."

Credit: ANI    Duration: 01:14Published

Related videos from verified sources

Covishield and Covaxin are safe, assures ICMR scientist [Video]

Covishield and Covaxin are safe, assures ICMR scientist

Indian Council of Medical Research, Scientist and Head of Epidemiology and Communicable Diseases Division, Dr. Samiran Panda while speaking to ANI assured that both Covishield and Covaxin are safe and..

Credit: ANI     Duration: 02:29Published
Covaxin's immunity will address mutants too: ICMR scientist [Video]

Covaxin's immunity will address mutants too: ICMR scientist

Indian Council of Medical Research, Scientist and Head of Epidemiology and Communicable Diseases Division, Dr. Samiran Panda said that the immunity produced by the Covaxin is expected to address the..

Credit: ANI     Duration: 01:24Published
Give me 1 week's time, will give you confirm data: Bharat Biotech MD on new virus strain [Video]

Give me 1 week's time, will give you confirm data: Bharat Biotech MD on new virus strain

While addressing a press conference via video conferencing in Hyderabad on January 04, the Chairman and Managing Director (MD) of Bharat Biotech International Limited, Dr Krishna Ella, on being asked..

Credit: ANI     Duration: 00:59Published

Related news from verified sources

Covaxin generated excellent safety data, says Bharat Biotech

Amid the criticism of the Drug Controller General of India (DCGI) for granting approval for emergency use of Covid-19 vaccine Covaxin, its manufacturer Bharat...
Mid-Day Also reported by •IndiaTimes

Bharat Biotech gets permission to manufacture Covaxin for sale

The Central Licensing Authority on Sunday granted permission to Hyderabad-based Bharat Biotech to manufacture 'Covaxin' for sale and distribution, after the...
Mid-Day Also reported by •IndiaTimesHinduDNA

'Covaxin is 200% safe': Bharat Biotech MD says Covaxin 'being targeted for being Indian company's product'

Bharat Biotech MD Krishna Ella on Tuesday refuted criticism surrounding his company's coronavirus vaccine saying that Covaxin is "200% safe" and it is being...
IndiaTimes